AsepticSure™ Production Agreement Awarded To SMTC

AsepticSure Logo
One of the World’s Most Innovative Disinfection Technologies – AsepticSure™ – to be manufactured by leading EMS Provider, SMTC

TORONTO, CANADA – November 21, 2011 – Medizone International (MZEI:OB MZEI:QB), a leading-edge research and development company that specializes in decontamination and sterilization systems and SMTC Corporation (NASDAQ: SMTX, TSX: SMX) (“SMTC”), a global electronics manufacturing services (EMS) provider, today jointly announce a new partnership agreement to manufacture Medizone’s AsepticSure hospital sterilization system.

Medizone International CEO Edwin Marshall commented on the partnership agreement: “In meeting with potential manufacturing partners it was soon clear that SMTC would be a great fit for us. They are able to provide a full range of complex electronic manufacturing and integrated service solutions at their Canadian facility, including New Product Introduction (NPI) services and PCBA manufacturing and system level integration. SMTC will leverage their expertise in global Supply Chain Management services from its large network of materials suppliers, and from its strong purchasing power, in order to help drive costs and support Medizone’s go-to-market plans.

“Another big plus is the fact that SMTC has manufacturing facilities in San Jose, California, Chihuahua, Mexico and Dongguan, China – a huge positive in our view, especially as we expand our geographic reach.”

Marshall went on to say, “Following on from the exceptional job that ADA Innovations, our development partner, has done in bringing the technology up to its current production-ready status, and having completed final performance validation of the production prototype AsepticSure™ system at our Innovation Park, Queen’s University research facilities, we’re now transferring the technology to SMTC’s manufacturing facility, headquartered in Toronto, Canada, in readiness for production. The initial AsepticSure™ units will be used for additional hospital and hotel testing as well as meeting delivery requirements for pre-orders received at the 2011 FIME medical purchasing show in Miami.”

Dr. Michael E. Shannon, Medizone’s President added, “During my years in government I had the opportunity to visit many electronic and medical device manufacturing facilities. This is one of the finest I have ever visited. Of special interest to both Ed and I is the SMTC ‘Copy Exact’ approach for each of their manufacturing facilities. This translates to a tremendous ability to respond to future anticipated ramp-ups in demand, in exceedingly short periods of time. Of course, their facility meets all of the necessary regulatory requirements such as ISO 9001:2008 and ISO 13485:2003 as well as IPC Class-validated lead-free process. All in all, SMTC will prove to be a great manufacturing partner for Medizone and one that clearly adds value to our company.”

SMTC’s John Bran, Vice President of Global Sales and Marketing added, “We’re fond of saying that ‘we’re the manufacturing partner to innovators around the world’. However, seldom has that statement been truer than it is today with Medizone International and its highly eco-friendly AsepticSure™ system. We believe both of our companies see this as a ‘great pairing’ moving forward. This is a product which offers the world’s newest and most powerful disinfection technology, which in turn offers unlimited growth potential over many market segments. As Dr. Shannon noted, SMTC is organized through our ‘Copy Exact’ processes to expand future production to our facilities outside of Ontario should international demand one day dictate this. We’re very pleased to have been selected to support Medizone with this enormously exciting initiative and look forward to contributing to its successes, both here in North America and around the world.”

About Medizone International, Inc: Medizone International, Inc. is engaged in final production development of its modular design AsepticSure™ Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures for building remediation. This Press Release contains certain forward looking statements that may involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission. For more information, visit: www.medizoneint.com

Email: operations@medizoneint.com

For press information on Medizone, please contact:

Bruce Smeaton, Investor Relations, Medizone International, Inc.

T: 001-415-331-0202

         E: bruce@medizoneint.com

 

———————————————————————————————————————————-

About SMTC Corporation: SMTC Corporation, founded in 1985, is a mid-size provider of end-to-end electronics manufacturing services (EMS) including PCBA production, systems integration and comprehensive testing services, enclosure fabrication, as well as product design, sustaining engineering and supply chain management services. SMTC facilities span a broad footprint in the United States, Canada, and Mexico, and a partnering relationship in China, with more than 1,500 full-time employees. SMTC services extend over the entire electronic product life cycle from the development and introduction of new products through to the growth, maturity and end-of-life phases. SMTC offers fully integrated contract manufacturing services with a distinctive approach to global original equipment manufacturers (OEMs) and emerging technology companies primarily within industrial, computing and communication market segments.

SMTC is a public company incorporated in Delaware with its shares traded on the Nasdaq National Market System under the symbol SMTX and on the Toronto Stock Exchange under the symbol SMX. For further information on SMTC Corporation, please visit our website at www.smtc.com (http://www.smtc.com/)

Public Relations information:

Tom Reilly

Director of Marketing

Telephone: (905) 413.1811

Email:public.relations@smtc.com

Investor Relations information:

Alex Walker

President and Co- Chief Executive Officer

Telephone: (905) 413.1190

Email: investorrelations@smtc.com

 

 

Contact:

Medizone International, Inc. (MZEI.OB)

4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

Investor Relations:

John Pentony

Investor Relations
Medizone International, Inc.

Telephone: (415) 331-0202

E: j.pentony@medizoneint.com

Media Contact:

Gary Hanauer

Media Relations
Medizone International, Inc.

Telephone: (510) 686-1238

E: GarHan@aol.com